Biron, P <br/><br/>
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Oct 1998 
 - 511-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0305-7453 
<br/><br/><label>Standard No.: </label>10.1093/jac/42.4.511  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Cefepime<br/>Cephalosporins--administration & dosage<br/>Cilastatin--administration & dosage<br/>Drug Therapy, Combination--administration & dosage<br/>Fever--chemically induced<br/>Humans<br/>Imipenem--administration & dosage<br/>Neoplasms--drug therapy<br/>Neutropenia--chemically induced<br/>Risk Factors<br/>Survival Analysis